rss
Br J Ophthalmol 89:1458-1461 doi:10.1136/bjo.2005.071407
  • Clinical science
    • Extended reports

Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery

Table 2

 Results of 3 months follow up examinations in two groups

Days after surgery Cases (n = 18) Controls (n = 16) p Value*
NS, no significant statistical difference.
2 test.
†Mean (SD).
Anterior chamber reaction (⩾2+)
1 3 (16.7%) 15 (93.8%) <0.001
3 4 (22.2%) 13 (81.2%) 0.001
7 1 (5.6%) 8 (50%) 0.003
14 0 (0%) 8 (50%) 0.001
30 0 (0%) 1 (6.2%) NS
90 0 (0%) 0 (0%) NS
Fibrin formation
1 0 (0%) 4 (25%) 0.024
3 0 (0%) 5 (31.3%) 0.01
7 0 (0%) 5 (31.3%) 0.01
14 0 (0%) 5 (31.3%) 0.01
30 0 (0%) 1 (6.2%) NS
90 0 (0%) 0 (0%) NS
Pigmented IOL precipitates
90 3 (16.7%) 14 (87.5%) <0.001
Posterior synechiae
90 0 (0%) 3 (18.7%) NS
Hyphaema ⩾2+
1 9 (50%) 3 (18.7%) NS
3 5 (28%) 2 (12.5%) NS
7 3 (16.7%) 1 (6.2%) NS
14 1 (5.6%) 0 (0%) NS
30 1 (5.6%) 0 (0%) NS
90 0 (0%) 0 (0%) NS
Corneal oedema ⩾2+
1 3 (16.7%) 2 (12.5%) NS
3 1 (5.6%) 1 (6.2%) NS
7 0 (0%) 1 (6.2%) NS
14 0 (0%) 0 (0%) NS
30 0 (0%) 0 (0%) NS
90 0 (0%) 0 (0%) NS
Intraocular pressure†
1 11.2 (1.1) 12.2 (0.8) NS
3 12.1 (0.6) 13.0 (0.9) NS
7 14.2 (1.2) 13.4 (1.1) NS
14 16.1 (1.1) 14.8 (1.0) NS
30 16.0 (1.2) 15.0 (1.0) NS
90 16.2 (1.2) 15.1 91.3) NS

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.